- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 6.15 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-mer
- Ligands
- 5 x FUC- BGC: beta-D-glucopyranose-(1-3)-alpha-L-fucopyranose(Post Translational Modification)
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.8: 3 residues within 4Å:- Chain G: N.63, K.480, A.481
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 3 residues within 4Å:- Chain G: E.149, N.178
- Chain H: N.191
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 3 residues within 4Å:- Chain I: N.63, K.480, A.481
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 3 residues within 4Å:- Chain I: E.149, N.178
- Chain J: N.191
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 4 residues within 4Å:- Chain K: S.25, N.26, P.173, V.196
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 2 residues within 4Å:- Chain K: W.118, N.119
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 4 residues within 4Å:- Chain L: S.25, N.26, P.173, V.196
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 2 residues within 4Å:- Chain L: W.118, N.119
No protein-ligand interaction detected (PLIP)- 21 x MAN: alpha-D-mannopyranose(Post Translational Modification)
MAN.16: 4 residues within 4Å:- Chain C: S.54, L.55, W.56, R.73
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:W.56, C:W.56, C:R.73, C:R.73
MAN.17: 2 residues within 4Å:- Chain C: T.58, W.59
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:S.57, C:T.58, C:T.58, C:W.59
MAN.18: 4 residues within 4Å:- Chain D: D.65, S.66, W.67, R.92
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:D.65, D:W.67, D:R.92, D:R.92
MAN.19: 6 residues within 4Å:- Chain D: G.68, E.69, W.70, R.114, W.178, G.179
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:G.68, D:W.70, D:R.114, D:G.179
MAN.20: 3 residues within 4Å:- Chain D: S.127, W.128, R.151
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:S.127, D:W.128, D:W.128, D:R.151, D:R.151
MAN.21: 4 residues within 4Å:- Chain D: S.132, T.133, W.134, R.147
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:S.132, D:W.134, D:R.147, D:R.147
MAN.22: 3 residues within 4Å:- Chain D: E.130, W.131, R.149
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:E.130, D:E.130, D:W.131, D:W.131, D:R.149, D:R.149
MAN.23: 5 residues within 4Å:- Chain D: G.5, W.6, R.28, C.42
- Ligands: MAN.24
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:W.6, D:R.28, D:R.28, D:C.42
MAN.24: 5 residues within 4Å:- Chain D: G.7, P.8, W.9, R.48
- Ligands: MAN.23
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:G.7, D:W.9, D:R.48
MAN.25: 4 residues within 4Å:- Chain E: S.54, L.55, W.56, R.73
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:W.56, E:W.56, E:R.73, E:R.73
MAN.26: 2 residues within 4Å:- Chain E: T.58, W.59
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:S.57, E:T.58, E:W.59
MAN.27: 4 residues within 4Å:- Chain E: G.111, W.112, R.134, P.148
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:W.112, E:W.112, E:R.134, E:R.134
MAN.28: 4 residues within 4Å:- Chain E: S.113, G.114, W.115, R.132
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:S.113, E:W.115, E:R.132, E:R.132
MAN.29: 4 residues within 4Å:- Chain E: G.116, P.117, W.118, R.130
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:W.118, E:W.118, E:R.130
MAN.30: 4 residues within 4Å:- Chain F: D.65, S.66, W.67, R.92
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:D.65, F:W.67, F:R.92, F:R.92
MAN.31: 6 residues within 4Å:- Chain F: G.68, E.69, W.70, R.114, W.178, G.179
5 PLIP interactions:5 interactions with chain F- Hydrogen bonds: F:G.68, F:W.70, F:R.114, F:W.178, F:G.179
MAN.32: 4 residues within 4Å:- Chain F: G.126, S.127, W.128, C.185
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:S.127, F:W.128, F:W.128
MAN.33: 4 residues within 4Å:- Chain F: S.132, T.133, W.134, R.147
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:S.132, F:W.134, F:R.147, F:R.147
MAN.34: 3 residues within 4Å:- Chain F: E.130, W.131, R.149
5 PLIP interactions:5 interactions with chain F- Hydrogen bonds: F:E.130, F:W.131, F:W.131, F:R.149, F:R.149
MAN.35: 5 residues within 4Å:- Chain F: G.5, W.6, R.28, C.42
- Ligands: MAN.36
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:W.6, F:R.28, F:R.28, F:C.42
MAN.36: 4 residues within 4Å:- Chain F: G.7, P.8, W.9
- Ligands: MAN.35
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:W.9, F:W.9
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.37: 6 residues within 4Å:- Chain J: N.915
- Chain K: D.17, S.19, S.21, T.94, D.130
4 PLIP interactions:3 interactions with chain K, 1 interactions with chain J- Metal complexes: K:S.19, K:S.21, K:T.94, J:N.915
MG.38: 6 residues within 4Å:- Chain H: N.915
- Chain L: D.17, S.19, S.21, T.94, D.130
4 PLIP interactions:3 interactions with chain L, 1 interactions with chain H- Metal complexes: L:S.19, L:S.21, L:T.94, H:N.915
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pedersen, D.V. et al., Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System. Front Immunol (2019)
- Release Date
- 2019-08-21
- Peptides
- Nanobody hFPNb1: AB
Properdin: CE
Properdin: DF
Complement C3: GI
Complement C3: HJ
Complement factor B: KL
Inhibitor: MN - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
RB
SC
UE
XD
VF
YG
AI
GH
BJ
HK
JL
LM
NN
Q
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 6.15 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-mer
- Ligands
- 5 x FUC- BGC: beta-D-glucopyranose-(1-3)-alpha-L-fucopyranose(Post Translational Modification)
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x MAN: alpha-D-mannopyranose(Post Translational Modification)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pedersen, D.V. et al., Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System. Front Immunol (2019)
- Release Date
- 2019-08-21
- Peptides
- Nanobody hFPNb1: AB
Properdin: CE
Properdin: DF
Complement C3: GI
Complement C3: HJ
Complement factor B: KL
Inhibitor: MN - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
RB
SC
UE
XD
VF
YG
AI
GH
BJ
HK
JL
LM
NN
Q